GBL's Healthcare Play, Agomab's Nasdaq Debut & The Battle for Warner Bros

About this Episode

Welcome to the first episode of The Finance Show, your biweekly briefing on Belgian and global corporate finance.

Belgian Deals

• GBL commits €500M to Rayner Surgical, making a major bet on the ophthalmology sector and marking one of the largest Belgian healthcare deals of the year.
• John Cockerill raises €300M to accelerate its green hydrogen and industrial transformation strategy across Europe and beyond.
• Agomab Therapeutics goes public on Nasdaq, raising $200M in one of Belgium's most closely watched biotech IPOs in recent years.

Global M&A

The battle for Warner Bros Discovery is heating up. Netflix enters the race with an $83B bid while Paramount Skydance counters with $108B. We break down the competing offers, what each buyer brings to the table, and why this deal matters for the future of streaming.

Plus: Trump's new tariff announcements and their potential ripple effects on European deal-making.

Analysis, context, and what's next. All in one episode.

New episodes every two weeks.